us > Maine > Oxford > Gilead > Latest & Local News
→ Put text on photo fast and free
Gilead news
District track finals: Mount Gilead boys make it three in a row - Marion Star
District track finals: Mount Gilead boys make it three in a row Marion Star
Published on 18 May 2024 | 8:14 pm
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff BioSpace
Published on 17 May 2024 | 7:00 am
Gilead Sciences brings on Omnicom to handle HIV portfolio - PR Week
Gilead Sciences brings on Omnicom to handle HIV portfolio PR Week
Published on 16 May 2024 | 6:39 pm
Bristol Myers' Breyanzi bags FDA nod to follow CAR-T rivals Gilead, Novartis into follicular lymphoma - FiercePharma
Bristol Myers' Breyanzi bags FDA nod to follow CAR-T rivals Gilead, Novartis into follicular lymphoma FiercePharma
Published on 16 May 2024 | 2:56 pm
'The Handmaid's Tale' Season 6: Release Date, Cast and Spoilers - Esquire UK
'The Handmaid's Tale' Season 6: Release Date, Cast and Spoilers Esquire UK
Published on 15 May 2024 | 7:00 am
Gilead Sciences Inc. stock rises Tuesday, still underperforms market - MarketWatch
Gilead Sciences Inc. stock rises Tuesday, still underperforms market MarketWatch
Published on 14 May 2024 | 8:45 pm
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance
Published on 10 May 2024 | 1:00 pm
Will Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs Of Around $75? - Forbes
Will Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs Of Around $75? Forbes
Published on 9 May 2024 | 7:00 am
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight - Yahoo Finance
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight Yahoo Finance
Published on 8 May 2024 | 7:00 am
AHF • AHF's 'Gilead for Greed' Lampoons Gilead Hypocrisy '...for Good' - AIDS Healthcare Foundation
AHF • AHF's 'Gilead for Greed' Lampoons Gilead Hypocrisy '...for Good' AIDS Healthcare Foundation
Published on 7 May 2024 | 7:00 am
US Urges Denial of Gilead Bid to Alter HIV Drug-Patents Judgment - Bloomberg Law
US Urges Denial of Gilead Bid to Alter HIV Drug-Patents Judgment Bloomberg Law
Published on 2 May 2024 | 6:57 pm
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript - Yahoo Finance
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript Yahoo Finance
Published on 30 April 2024 | 7:00 am
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data - Clinical Trials Arena
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data Clinical Trials Arena
Published on 29 April 2024 | 7:00 am
Gilead writes $2.4B off Trodelvy as CEO underscores 'time of focused execution' - FiercePharma
Gilead writes $2.4B off Trodelvy as CEO underscores 'time of focused execution' FiercePharma
Published on 26 April 2024 | 7:00 am
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline - BioSpace
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline BioSpace
Published on 26 April 2024 | 7:00 am
Gilead gives up on $4.9B antibody magrolimab - Fierce Biotech
Gilead gives up on $4.9B antibody magrolimab Fierce Biotech
Published on 26 April 2024 | 7:00 am
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again - Investor's Business Daily
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again Investor's Business Daily
Published on 26 April 2024 | 7:00 am
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript - The Motley Fool
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript The Motley Fool
Published on 25 April 2024 | 7:00 am
Gilead’s quarterly loss is narrower than expected - MarketWatch
Gilead’s quarterly loss is narrower than expected MarketWatch
Published on 25 April 2024 | 7:00 am
Gilead posts quarterly loss on acquisition charge, revenue rises 5% - Yahoo Finance
Gilead posts quarterly loss on acquisition charge, revenue rises 5% Yahoo Finance
Published on 25 April 2024 | 7:00 am
Gilead posts quarterly loss on acquisition charge, revenue rises 5% - Reuters
Gilead posts quarterly loss on acquisition charge, revenue rises 5% Reuters
Published on 25 April 2024 | 7:00 am
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ... - Yahoo Finance
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ... Yahoo Finance
Published on 25 April 2024 | 7:00 am
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect? - Yahoo Finance
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect? Yahoo Finance
Published on 22 April 2024 | 7:00 am
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know Yahoo Finance
Published on 18 April 2024 | 7:00 am
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ... - PR Newswire
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ... PR Newswire
Published on 18 April 2024 | 7:00 am
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ... - PR Newswire
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ... PR Newswire
Published on 15 April 2024 | 7:00 am
Gilead enlists Grammy nominee Raheem DeVaughn in HIV education, prevention initiative - FiercePharma
Gilead enlists Grammy nominee Raheem DeVaughn in HIV education, prevention initiative FiercePharma
Published on 12 April 2024 | 7:00 am
Gilead finds new way to raise HIV awareness, locking in with dancer for voguing workshop - FiercePharma
Gilead finds new way to raise HIV awareness, locking in with dancer for voguing workshop FiercePharma
Published on 3 April 2024 | 7:00 am
Gilead pays $43.5M for early-phase IL-12 prospect from Xilio as biotech reduces head count - Fierce Biotech
Gilead pays $43.5M for early-phase IL-12 prospect from Xilio as biotech reduces head count Fierce Biotech
Published on 28 March 2024 | 7:00 am
Xilio and Gilead partner up for IL-12 therapeutic development - Pharmaceutical Technology
Xilio and Gilead partner up for IL-12 therapeutic development Pharmaceutical Technology
Published on 28 March 2024 | 7:00 am
Ropes & Gray Advises Xilio Therapeutics in Gilead Sciences Exclusive Global License Agreement Up to $647.5 Million ... - Ropes & Gray LLP
Ropes & Gray Advises Xilio Therapeutics in Gilead Sciences Exclusive Global License Agreement Up to $647.5 Million ... Ropes & Gray LLP
Published on 27 March 2024 | 7:00 am
Gilead concludes acquisition of CymaBay Therapeutics for $4.3bn - Pharmaceutical Technology
Gilead concludes acquisition of CymaBay Therapeutics for $4.3bn Pharmaceutical Technology
Published on 25 March 2024 | 7:00 am
Gilead Win on US HIV-Drug Patents Survives, But New Risk Rises - Bloomberg Law
Gilead Win on US HIV-Drug Patents Survives, But New Risk Rises Bloomberg Law
Published on 25 March 2024 | 7:00 am
Gilead Sciences Announces Completion of Acquisition of CymaBay - Yahoo Finance
Gilead Sciences Announces Completion of Acquisition of CymaBay Yahoo Finance
Published on 22 March 2024 | 7:00 am
Gilead CEO Daniel O'Day collects 5% pay raise to $22.6M, his largest compensation package in years - FiercePharma
Gilead CEO Daniel O'Day collects 5% pay raise to $22.6M, his largest compensation package in years FiercePharma
Published on 19 March 2024 | 7:00 am
Gilead CAR-T cancer therapy capacity to quadruple by 2026 - Reuters
Gilead CAR-T cancer therapy capacity to quadruple by 2026 Reuters
Published on 15 March 2024 | 7:00 am
Gilead Sciences revenue 2006-2023 - Statista
Gilead Sciences revenue 2006-2023 Statista
Published on 15 March 2024 | 7:00 am
Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan - STAT
Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan STAT
Published on 14 March 2024 | 7:00 am
AIDS advocates welcome 'greedy Gilead' to Miami with protests - FiercePharma
AIDS advocates welcome 'greedy Gilead' to Miami with protests FiercePharma
Published on 14 March 2024 | 7:00 am
AHF • Protesters Keep Hammering 'Greedy Gilead' on Price Gouging - AIDS Healthcare Foundation
AHF • Protesters Keep Hammering 'Greedy Gilead' on Price Gouging AIDS Healthcare Foundation
Published on 12 March 2024 | 7:00 am
Gilead launches patient hub to 'expose' realities of living with metastatic breast cancer - FiercePharma
Gilead launches patient hub to 'expose' realities of living with metastatic breast cancer FiercePharma
Published on 11 March 2024 | 7:00 am
Gilead and Merus enter trispecific antibody discovery deal - Pharmaceutical Technology
Gilead and Merus enter trispecific antibody discovery deal Pharmaceutical Technology
Published on 7 March 2024 | 8:00 am
Gilead-Merck's therapy maintains HIV suppression in trial - Clinical Trials Arena
Gilead-Merck's therapy maintains HIV suppression in trial Clinical Trials Arena
Published on 7 March 2024 | 8:00 am
Gilead bets $1.5B-plus on Merus' trispecifc T-cell engagers - Fierce Biotech
Gilead bets $1.5B-plus on Merus' trispecifc T-cell engagers Fierce Biotech
Published on 6 March 2024 | 8:00 am
Gilead Sciences Signs Yet Another R&D Alliance for Multi-Target Cancer Therapies - MedCity News
Gilead Sciences Signs Yet Another R&D Alliance for Multi-Target Cancer Therapies MedCity News
Published on 6 March 2024 | 8:00 am
Key takeaways from Gilead's Innovation Talk at re:Invent 2023 | Amazon Web Services - AWS Blog
Key takeaways from Gilead's Innovation Talk at re:Invent 2023 | Amazon Web Services AWS Blog
Published on 6 March 2024 | 8:00 am
Abingworth to Provide Gilead Sciences Up To $210 Million in Funding | News & Events | Goodwin - Goodwin Procter
Abingworth to Provide Gilead Sciences Up To $210 Million in Funding | News & Events | Goodwin Goodwin Procter
Published on 5 March 2024 | 8:00 am
CymaBay Investor Alleges Gilead Buyout Filing Omits Conflicts - Bloomberg Law
CymaBay Investor Alleges Gilead Buyout Filing Omits Conflicts Bloomberg Law
Published on 1 March 2024 | 8:00 am
Gilead Secures $210M from VC to Build Trodelvy’s Clinical Case in NSCLC - BioSpace
Gilead Secures $210M from VC to Build Trodelvy’s Clinical Case in NSCLC BioSpace
Published on 1 March 2024 | 8:00 am
In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials - FiercePharma
In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials FiercePharma
Published on 29 February 2024 | 8:00 am
Gilead Set to Donate $12.6 Million In Funding for HIV Prevention for Black Cisgender, Transgender Women - Pharmacy Times
Gilead Set to Donate $12.6 Million In Funding for HIV Prevention for Black Cisgender, Transgender Women Pharmacy Times
Published on 29 February 2024 | 8:00 am
Howard University Awarded Nearly $1 Million for HIV Prevention Among Black Cisgender and Transgender Women - The Dig
Published on 29 February 2024 | 8:00 am
Gilead funding aimed at Black women and girls impacted by HIV - FiercePharma
Gilead funding aimed at Black women and girls impacted by HIV FiercePharma
Published on 28 February 2024 | 8:00 am
PhRMA taps Gilead CEO Dan O'Day as its new board chair - FiercePharma
PhRMA taps Gilead CEO Dan O'Day as its new board chair FiercePharma
Published on 21 February 2024 | 8:00 am
Yet another clinical hold for Gilead’s magrolimab trials - Pharmaceutical Technology
Yet another clinical hold for Gilead’s magrolimab trials Pharmaceutical Technology
Published on 19 February 2024 | 8:00 am
Gilead signs antibody deal with Biocytogen amid ADC buzz - Pharmaceutical Technology
Gilead signs antibody deal with Biocytogen amid ADC buzz Pharmaceutical Technology
Published on 19 February 2024 | 8:00 am
Gilead Sciences 'strengthens commitment' to inflammatory disease with new research site - BioPharma-Reporter.com
Gilead Sciences 'strengthens commitment' to inflammatory disease with new research site BioPharma-Reporter.com
Published on 19 February 2024 | 8:00 am
Gilead Suspends Patient Enrollment for Magrolimab in Solid Tumor Trials - BioSpace
Gilead Suspends Patient Enrollment for Magrolimab in Solid Tumor Trials BioSpace
Published on 16 February 2024 | 8:00 am
Dragonfly and Gilead enter partnership for cancer therapy - Pharmaceutical Technology
Dragonfly and Gilead enter partnership for cancer therapy Pharmaceutical Technology
Published on 16 February 2024 | 8:00 am
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials - Reuters
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials Reuters
Published on 15 February 2024 | 8:00 am
Gilead might be held responsible for not developing a drug - STAT - STAT
Gilead might be held responsible for not developing a drug - STAT STAT
Published on 13 February 2024 | 8:00 am
Gilead aims to cash in on liver disease wave with $4.6bn CymaBay deal - Pharmaceutical Technology
Gilead aims to cash in on liver disease wave with $4.6bn CymaBay deal Pharmaceutical Technology
Published on 13 February 2024 | 8:00 am
Gilead to Buy CymaBay, Lead Liver Disease Asset Seladelpar for $4.3B - BioSpace
Gilead to Buy CymaBay, Lead Liver Disease Asset Seladelpar for $4.3B BioSpace
Published on 12 February 2024 | 8:00 am
Gilead to Buy Liver Drugmaker for $4.3 Billion Equity Value - Bloomberg
Gilead to Buy Liver Drugmaker for $4.3 Billion Equity Value Bloomberg
Published on 12 February 2024 | 8:00 am
Gilead to buy CymaBay for $4.3 bln in bets on liver disease treatment - Reuters
Gilead to buy CymaBay for $4.3 bln in bets on liver disease treatment Reuters
Published on 12 February 2024 | 8:00 am
AHF • AHF Hammers Gilead Over Continued Profiteering - AIDS Healthcare Foundation
AHF • AHF Hammers Gilead Over Continued Profiteering AIDS Healthcare Foundation
Published on 8 February 2024 | 8:00 am
Gilead Sciences Inc (GILD) Reports Mixed Results Amidst Growth in HIV and Oncology - Yahoo Finance
Gilead Sciences Inc (GILD) Reports Mixed Results Amidst Growth in HIV and Oncology Yahoo Finance
Published on 8 February 2024 | 8:00 am
FDA puts Gilead's magrolimab trials on clinical hold - Clinical Trials Arena
FDA puts Gilead's magrolimab trials on clinical hold Clinical Trials Arena
Published on 8 February 2024 | 8:00 am
Gilead's at 'just the beginning' of cell therapy movement: exec - FiercePharma
Gilead's at 'just the beginning' of cell therapy movement: exec FiercePharma
Published on 7 February 2024 | 8:00 am
Gilead’s Q4 Revenue Slips on Weaker HIV and COVID-19 Sales, Amid Phase III Flops - BioSpace
Gilead’s Q4 Revenue Slips on Weaker HIV and COVID-19 Sales, Amid Phase III Flops BioSpace
Published on 7 February 2024 | 8:00 am
Gilead Sciences posts $5.61bn net income in FY23 - Pharmaceutical Technology
Gilead Sciences posts $5.61bn net income in FY23 Pharmaceutical Technology
Published on 7 February 2024 | 8:00 am
US FDA puts hold on Gilead's blood cancer therapy trials - Reuters
US FDA puts hold on Gilead's blood cancer therapy trials Reuters
Published on 7 February 2024 | 8:00 am
Gilead quarterly revenue drops 4%, oral COVID drug fails trial - Reuters
Gilead quarterly revenue drops 4%, oral COVID drug fails trial Reuters
Published on 6 February 2024 | 8:00 am
Ted W. Love, MD | Gilead - Gilead Sciences
Ted W. Love, MD | Gilead Gilead Sciences
Published on 2 February 2024 | 10:30 am
Former Volunteer Fire Department Treasurer Indicted for Theft - Tennessee Comptroller of the Treasury
Former Volunteer Fire Department Treasurer Indicted for Theft Tennessee Comptroller of the Treasury
Published on 1 February 2024 | 8:00 am
Gilead and Arcus Biosciences expand oncology partnership deal - Pharmaceutical Technology
Gilead and Arcus Biosciences expand oncology partnership deal Pharmaceutical Technology
Published on 30 January 2024 | 8:00 am
Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33% - Reuters
Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33% Reuters
Published on 29 January 2024 | 8:00 am
What to make of Gilead's Trodelvy troubles and Elevation Oncology's rise - STAT
What to make of Gilead's Trodelvy troubles and Elevation Oncology's rise STAT
Published on 25 January 2024 | 8:00 am
FDA tweaks demand for safety update on Gilead's Tecartus label - FiercePharma
FDA tweaks demand for safety update on Gilead's Tecartus label FiercePharma
Published on 24 January 2024 | 8:00 am
GILD Stock Quote Price and Forecast - CNN
GILD Stock Quote Price and Forecast CNN
Published on 22 January 2024 | 11:23 pm
Gilead's Trodelvy fails to meet main goal in lung cancer trial - Reuters
Gilead's Trodelvy fails to meet main goal in lung cancer trial Reuters
Published on 22 January 2024 | 8:00 am
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff - FiercePharma
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff FiercePharma
Published on 22 January 2024 | 8:00 am
Gilead stock falls after lung cancer study results disappoint - CNBC
Gilead stock falls after lung cancer study results disappoint CNBC
Published on 22 January 2024 | 8:00 am
Gilead’s ADC Trodelvy Fails Phase III NSCLC Study, Stock Drops 10% - BioSpace
Gilead’s ADC Trodelvy Fails Phase III NSCLC Study, Stock Drops 10% BioSpace
Published on 22 January 2024 | 8:00 am
Gilead $247 Million Antitrust Deal Over HIV Drugs Gets Final Nod - Bloomberg Law
Gilead $247 Million Antitrust Deal Over HIV Drugs Gets Final Nod Bloomberg Law
Published on 20 January 2024 | 8:00 am
Gilead calls off Oceanside manufacturing expansion, uproots biologics development team - FiercePharma
Gilead calls off Oceanside manufacturing expansion, uproots biologics development team FiercePharma
Published on 16 January 2024 | 8:00 am
Appeals court allows unique argument in Gilead's legal battle over HIV meds - FiercePharma
Appeals court allows unique argument in Gilead's legal battle over HIV meds FiercePharma
Published on 12 January 2024 | 8:00 am
Gilead to Face HIV Drug Development Delay Negligence Claim (1) - Bloomberg Law
Gilead to Face HIV Drug Development Delay Negligence Claim (1) Bloomberg Law
Published on 10 January 2024 | 8:00 am
Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced - FiercePharma
Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced FiercePharma
Published on 29 November 2023 | 8:00 am
Cancer 'steals possibilities,' but Gilead is 'taking it back' in new oncology campaign - FiercePharma
Cancer 'steals possibilities,' but Gilead is 'taking it back' in new oncology campaign FiercePharma
Published on 16 November 2023 | 8:00 am
Mt. Gilead Road Improvements Project - City of Keller
Mt. Gilead Road Improvements Project City of Keller
Published on 2 November 2023 | 10:16 pm
Advancing Health Equity | Gilead - Gilead Sciences
Advancing Health Equity | Gilead Gilead Sciences
Published on 26 October 2023 | 7:00 am
Diversity in Clinical Trials - Gilead Sciences
Diversity in Clinical Trials Gilead Sciences
Published on 17 October 2023 | 12:49 pm
Zeroing In: Ending the HIV Epidemic | Gilead - Gilead Sciences
Zeroing In: Ending the HIV Epidemic | Gilead Gilead Sciences
Published on 21 August 2023 | 9:45 pm
Zeroing In: Ending the HIV Epidemic - Gilead Sciences
Zeroing In: Ending the HIV Epidemic Gilead Sciences
Published on 21 August 2023 | 9:45 pm